Skip to main content

Table 2 Baseline characteristics of the study patients

From: Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance

 

Artemether–lumefantrine

Artesunate–amodiaquine

Doba

Kelo

Kayoma

Doba

Kelo

Kayoma

Number of patients

31

48

35

33

33

35

Males, %

61%

56%

40%

58%

58%

60%

Age (years)

      

Mean (sd*)

3.3 (1.6)

2.6 (1.4)

3.2 (1.5)

2.9 (1.5)

2.7 (1.7)

2.7 (1.5)

Range (min–max)

0.5–5

0.5–5

0.5–5

0.5–5

0.5–5

0.5–5

Temperature (°C), day 0

      

Mean (sd*),

38.1 (1.2)

38.1 (1.3)

38.6 (0.8)

38 (1.3)

38 (1.2)

38.3 (0.8)

Parasitaemia (µl), day 0

      

Geometric mean

11,491

10,932

5073

13,909

12,524

4777

Range (min–max)

2000–20,000

2003–80,000

2000–40,000

2560–97,560

2000–90,000

2000–16,000

  1. *Standard deviation